These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. An introductory note to CHMP guidelines: choice of the non-inferiority margin and data monitoring committees. Brown D; Volkers P; Day S Stat Med; 2006 May; 25(10):1623-7. PubMed ID: 16639776 [TBL] [Abstract][Full Text] [Related]
8. [Statistical notes. From superiority to non-inferiority clinical trials: a leap in the dark?]. Marubini E; Rebora P; Reina G Ital Heart J Suppl; 2004 Sep; 5(9):712-9. PubMed ID: 15568609 [TBL] [Abstract][Full Text] [Related]
9. [Equivalence and non-inferiority trials]. Lange S; Bender R; Ziegler A Dtsch Med Wochenschr; 2007; 132 Suppl 1():e53-6. PubMed ID: 17530600 [No Abstract] [Full Text] [Related]
10. Three-sided hypothesis testing: simultaneous testing of superiority, equivalence and inferiority. Goeman JJ; Solari A; Stijnen T Stat Med; 2010 Sep; 29(20):2117-25. PubMed ID: 20658478 [TBL] [Abstract][Full Text] [Related]
11. Committee for Medicinal Products for Human Use (CHMP) guideline on the choice of the non-inferiority margin. ; ; Stat Med; 2006 May; 25(10):1628-38. PubMed ID: 16639773 [No Abstract] [Full Text] [Related]
12. A score test for establishing non-inferiority with respect to short-term survival in two-sample comparisons with identical proportions of long-term survivors. Broët P; Tubert-Bitter P; De Rycke Y; Moreau T Stat Med; 2003 Mar; 22(6):931-40. PubMed ID: 12627410 [TBL] [Abstract][Full Text] [Related]
13. An introductory note to the CHMP guidelines: choice of the non-inferiority margin and data monitoring committees by David Brown, Peter Volkers and Simon Day, Statistics in Medicine 2006; 25:1623-1627. Stat Med; 2007 Jan; 26(1):230-3; author reply 234-5. PubMed ID: 16900566 [No Abstract] [Full Text] [Related]
14. Assessing non-inferiority: a combination approach. Gao P; Ware JH Stat Med; 2008 Feb; 27(3):392-406. PubMed ID: 17575568 [TBL] [Abstract][Full Text] [Related]
15. Issues on the selection of non-inferiority margin in clinical trials. Hou Y; Wu XY; Li K Chin Med J (Engl); 2009 Feb; 122(4):466-70. PubMed ID: 19302756 [TBL] [Abstract][Full Text] [Related]
16. A mixed approach for proving non-inferiority in clinical trials with binary endpoints. Rousson V; Seifert B Biom J; 2008 Apr; 50(2):190-204. PubMed ID: 18311852 [TBL] [Abstract][Full Text] [Related]
17. What does 'non-inferior to' really mean? A clinician thinking out loud. Ricci S Cerebrovasc Dis; 2010; 29(6):607-8. PubMed ID: 20413972 [TBL] [Abstract][Full Text] [Related]
18. Nonparametric non-inferiority analyses in the three-arm design with active control and placebo. Munzel U Stat Med; 2009 Dec; 28(29):3643-56. PubMed ID: 19768691 [TBL] [Abstract][Full Text] [Related]
19. [Non-inferiority trial used in venous thromboembolic disease. A warily interpretation is necessary!]. Pérard L; Hot A; Cucherat M; Simon M; Desmurs H; Coppéré B; Girard-Madoux MH; Boissel JP; Ninet J Rev Med Interne; 2007 Nov; 28(11):731-6. PubMed ID: 17597259 [TBL] [Abstract][Full Text] [Related]
20. [Non-inferiority and equivalence trials: Key methodological issues]. Herr M; Descatha A; Aegerter P Rev Med Interne; 2018 May; 39(5):352-359. PubMed ID: 28693836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]